AQEMIA

AQEMIA is a company specializing in computational drug discovery using quantum physics and machine learning. They have developed a proprietary technology that can predict the affinity between a drug and its target. This technology helps pharmaceutical companies accelerate their drug discovery process by identifying the most promising molecules more quickly and efficiently.

Based in Paris, AQEMIA's mission is to help in the creation of new, more effective drugs. They do this by providing predictive models that can be used in the initial stages of drug discovery, thus reducing the time and resources spent on laboratory testing. Their solution is designed to be used across a variety of therapeutic areas, including oncology, neurology, and infectious diseases.